94 related articles for article (PubMed ID: 21498714)
1. Overcoming multidrug resistance in human lung cancer with novel benzo[a]quinolizin-4-ones.
Kanintronkul Y; Worayuthakarn R; Thasana N; Winayanuwattikun P; Pattanapanyasat K; Surarit R; Ruchirawat S; Svasti J
Anticancer Res; 2011 Mar; 31(3):921-7. PubMed ID: 21498714
[TBL] [Abstract][Full Text] [Related]
2. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
[TBL] [Abstract][Full Text] [Related]
3. Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and P‑glycoprotein expression.
Sun L; Chen W; Qu L; Wu J; Si J
Mol Med Rep; 2013 Dec; 8(6):1883-7. PubMed ID: 24145579
[TBL] [Abstract][Full Text] [Related]
4. microRNA expression profiling in multidrug resistance of the 5‑Fu‑induced SGC‑7901 human gastric cancer cell line.
Wang Y; Gu X; Li Z; Xiang J; Jiang J; Chen Z
Mol Med Rep; 2013 May; 7(5):1506-10. PubMed ID: 23525256
[TBL] [Abstract][Full Text] [Related]
5. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
6. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
Wang G; Rong J; Zhou Z; Duo J
Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
[TBL] [Abstract][Full Text] [Related]
7. Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
Campling BG; Young LC; Baer KA; Lam YM; Deeley RG; Cole SP; Gerlach JH
Clin Cancer Res; 1997 Jan; 3(1):115-22. PubMed ID: 9815546
[TBL] [Abstract][Full Text] [Related]
8. A novel podophyllotoxin derivative (YB-1EPN) induces apoptosis and down-regulates express of P-glycoprotein in multidrug resistance cell line KBV200.
Chen H; Bi W; Cao B; Yang Z; Chen S; Shang H; Yu P; Yang J
Eur J Pharmacol; 2010 Feb; 627(1-3):69-74. PubMed ID: 19879873
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
Xu D; Lu Q; Hu X
Cancer Lett; 2006 Nov; 243(2):274-80. PubMed ID: 16406853
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.
Susa M; Choy E; Yang C; Schwab J; Mankin H; Hornicek F; Duan Z
J Biomol Screen; 2010 Mar; 15(3):287-96. PubMed ID: 20150589
[TBL] [Abstract][Full Text] [Related]
11. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
Xiang W; Gao A; Liang H; Li C; Gao J; Wang Q; Shuang B; Zhang J; Yan Y; Wang X
Toxicol In Vitro; 2010 Sep; 24(6):1474-81. PubMed ID: 20656007
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screening for daunorubicin-mediated drug resistance identifies mometasone furoate as a novel ABCB1-reversal agent.
Winter SS; Lovato DM; Khawaja HM; Edwards BS; Steele ID; Young SM; Oprea TI; Sklar LA; Larson RS
J Biomol Screen; 2008 Mar; 13(3):185-93. PubMed ID: 18310528
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of multidrug resistance of human small cell lung cancer cell line H446/VP.
Wang YL; Yan YL; Zhou NJ; Han S; Zhao JX; Cao CL; Lü YH
Chin Med J (Engl); 2010 Nov; 123(22):3299-303. PubMed ID: 21163134
[TBL] [Abstract][Full Text] [Related]
14. Reversal of cancer multidrug resistance by green tea polyphenols.
Mei Y; Qian F; Wei D; Liu J
J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
[TBL] [Abstract][Full Text] [Related]
15. [Involvement of bcl-2 in multidrug resistance in human small cell lung cancer cell subline H446/DDP].
Ji FY; Qian GS; Qian P; Chen Y; Guo RL; Li SP; Huang GJ
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Mar; 29(3):156-60. PubMed ID: 16677475
[TBL] [Abstract][Full Text] [Related]
16. Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells.
Buys TP; Chari R; Lee EH; Zhang M; MacAulay C; Lam S; Lam WL; Ling V
Genes Chromosomes Cancer; 2007 Dec; 46(12):1069-79. PubMed ID: 17726699
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Stat1-HDAC4 confers resistance to etoposide through enhanced multidrug resistance 1 expression in human A549 lung cancer cells.
Kaewpiboon C; Srisuttee R; Malilas W; Moon J; Oh S; Jeong HG; Johnston RN; Assavalapsakul W; Chung YH
Mol Med Rep; 2015 Mar; 11(3):2315-21. PubMed ID: 25395162
[TBL] [Abstract][Full Text] [Related]
19. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
[TBL] [Abstract][Full Text] [Related]
20. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
